help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NEVIÈRE, R.
Right arrow Articles by MARCHETTI, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NEVIÈRE, R.
Right arrow Articles by MARCHETTI, P.

Am. J. Respir. Crit. Care Med., Volume 163, Number 1, January 2001, 218-225

Caspase Inhibition Prevents Cardiac Dysfunction and Heart Apoptosis in a Rat Model of Sepsis

RÉMI NEVIÈRE, HAROLD FAUVEL, CLAUDE CHOPIN, PIERRE FORMSTECHER, and PHILIPPE MARCHETTI

INSERM U459, Faculté de Médecine, EA 2689, Pavillon Vancostenobel, Faculté de Médecine, and Département de Physiologie, Faculté de Médecine, Lille Cedex, France

Despite intensive therapy, severe septic shock is commonly associated with myocardial dysfunction and death in humans. No new therapies have proven efficiency against cardiovascular alterations in sepsis. Here, we addressed the question of a beneficial effect of pharmacological inhibition of caspases on myocardial dysfunction following endotoxin treatment. Hearts from rats treated with endotoxin (10 mg/kg, intravenously) were isolated 4 h posttreatment for analysis. Assessment of myocardial contractility ex vivo and detection of apoptosis were performed. Hearts from endotoxin-treated rats displayed multiple caspase activities and also typical apoptosis pattern as detected by TUNEL, DNA fragmentation assays, and cytochrome c release as compared with control rats. z-VAD.fmk (3 mg/kg, intravenously), a broad spectrum caspase inhibitor (but not the irrelevant peptide z-FA.fmk), in coinjection with endotoxin, not only reduced caspase activities and nuclear apoptosis but also completely prevented endotoxin-induced myocardial dysfunction evaluated 4 h and even 14 h after endotoxin challenge. These data indicate that caspase activation plays an important role in myocardial cell dysfunction. Moreover, these results suggest that inhibitors of caspases may have important therapeutic applications in sepsis.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
X. Li, Y. Li, L. Shan, E Shen, R. Chen, and T. Peng
Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia
Cardiovasc Res, July 1, 2009; 83(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. Ronco, J. A. Kellum, R. Bellomo, and A. A. House
Potential Interventions in Sepsis-Related Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 531 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. S. Supinski, X. Ji, W. Wang, and L. A. Callahan
The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction
J Appl Physiol, April 1, 2007; 102(4): 1649 - 1657.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. S. Supinski and L. A. Callahan
Caspase activation contributes to endotoxin-induced diaphragm weakness
J Appl Physiol, June 1, 2006; 100(6): 1770 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. S. Supinski and L. A. Callahan
Polyethylene Glycol-Superoxide Dismutase Prevents Endotoxin-induced Cardiac Dysfunction
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J.-B. Park, I.-C. Park, S.-J. Park, H.-O. Jin, J.-K. Lee, and K. D. Riew
Anti-Apoptotic Effects of Caspase Inhibitors on Rat Intervertebral Disc Cells
J. Bone Joint Surg. Am., April 1, 2006; 88(4): 771 - 779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Ashare, M. M. Monick, L. S. Powers, T. Yarovinsky, and G. W. Hunninghake
Severe Bacteremia Results in a Loss of Hepatic Bacterial Clearance
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 644 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kumar, A. Kumar, P. Michael, D. Brabant, A. M. Parissenti, C. V. Ramana, X. Xu, and J. E. Parrillo
Human Serum from Patients with Septic Shock Activates Transcription Factors STAT1, IRF1, and NF-{kappa}B and Induces Apoptosis in Human Cardiac Myocytes
J. Biol. Chem., December 30, 2005; 280(52): 42619 - 42626.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Syed, H. S. Hahn, A. Odley, Y. Guo, J. G. Vallejo, R. A. Lynch, D. L. Mann, R. Bolli, and G. W. Dorn II
Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia
Circ. Res., May 27, 2005; 96(10): 1103 - 1109.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Lancel, O. Joulin, R. Favory, J. F. Goossens, J. Kluza, C. Chopin, P. Formstecher, P. Marchetti, and R. Neviere
Ventricular Myocyte Caspases Are Directly Responsible for Endotoxin-Induced Cardiac Dysfunction
Circulation, May 24, 2005; 111(20): 2596 - 2604.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Gras-Le Guen, A. Jarry, G. Vallette, C. Toquet, C. Colombeix, C. L. Laboisse, G. Potel, J-C. Roze, D. Bugnon, and T. Debillon
Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung
Eur. Respir. J., January 1, 2005; 25(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. A. Webster and N. H. Bishopric
Apoptosis Inhibitors for Heart Disease
Circulation, December 16, 2003; 108(24): 2954 - 2956.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Suzuki, E. Bayna, E. Dalle Molle, and W. Y. W. Lew
Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 482 - 488.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Smith, S. Lecour, and M. N Sack
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Cardiovasc Res, August 15, 2002; 55(3): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Critical Care Medicine in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 565 - 583.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. FAUVEL, P. MARCHETTI, G. OBERT, O. JOULAIN, C. CHOPIN, P. FORMSTECHER, and R. NEVIERE
Protective Effects of Cyclosporin A from Endotoxin-induced Myocardial Dysfunction and Apoptosis in Rats
Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Fauvel, P. Marchetti, C. Chopin, P. Formstecher, and R. Neviere
Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1608 - H1614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society
  CCM abstracts